Navigating the landscape of end-of-life care and access to medications like this drug in New South Wales, Australia, requires a careful grasp of the intricate legal structure. Currently, this powerful sedative does not have a official place on the Pharmaceutical Benefits Scheme (PBS) and is therefore not regularly prescribed by clinical professiona